Genesee Capital Advisors »

Dyne Therapeutics shares owned by Genesee Capital Advisors

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Genesee Capital Advisors from 13F filings

Historical chart of Genesee Capital Advisors investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Genesee Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Genesee Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $577k 16k 35.29

More positions owned by Genesee Capital Advisors

Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
First Tr Exchange Traded Tech Alphadex (FXL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Vaneck Etf Trust Semiconductr Etf (SMH)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Spdr Ser Tr Prtflo S&p500 Hi (SPYD)
First Tr Sml Cp Core Alpha F Com Shs (FYX)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Us Oil Eq&sv Etf (IEZ)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Spdr Ser Tr Portfolio Ln Tsr (SPTL)
Ishares Tr Rus 1000 Etf (IWB)

View all positions for Genesee Capital Advisors

Top funds holding Dyne Therapeutics

Atlas Venture Life Science Advisors
Fcpm Iii Services B.v.
BlackRock
RA Capital Management
Vanguard Group
Henderson Group
Citadel Advisors
Deep Track Capital
FMR
State Street Corporation
Rtw Investments
TCG Crossover Management
T. Rowe Price Associates
Adage Capital Partners GP
VR Adviser

View all funds holding Dyne Therapeutics